New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Inhibrx Biosciences, Inc. (INBX) vs KARDIGAN INC (KARD)
- Inhibrx Biosciences, Inc. INBX 68.97 −7.21%
- KARDIGAN INC KARD 11.54 −7.83%
Inhibrx Biosciences, Inc. and KARDIGAN INC are both Biotechnology companies. Inhibrx Biosciences, Inc. and KARDIGAN INC are of similar size ($1.2B and $1.1B). Across the 9 metrics below, Inhibrx Biosciences, Inc. leads on 7 and KARDIGAN INC on 2.
Valuation
Profitability
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack